Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chinese Academy of Sciences | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether the morbidity of hepatitis C with Chinese population.
Hepatitis C virus (HCV) infection rate in China is about 3%, which means about 30 million patients. More importantly, many of those patients with chronic hepatitis C eventually develop cirrhosis and hepatocellular carcinoma(HCC).Our survey found the rate of hepatitis c infection in northeastern China without intervention is 34.3%, due to the abuse of caffeine sodium benzoate. This population has the similar mode of transmission, which is a fine study of the natural outcome hepatitis C. We plan to carry out epidemiological studies for this population, review of the influencing factors of the disease, and analyze the host factors that can effect the prognosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HCV |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Blood Anti-HCV | Co-infection status are analyzed. | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Alanine Aminotransferase (ALT) and Aspartate transaminase (AST) | ALT AST are assayed to detect the hepatic function. | Baseline |
| Fibrosis stage | Fibrosis is analyzed with Fibroscan. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients are from the northeast of China. Most of the patients have been infected by the hepatitis c virus due to the drug abuse. Many of them share the same syringe for drug intravenous injection. However, HIV infection has been rarely detected.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Junqi Niu, PhD/MD | The First Hospital of Jilin University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| First Hospital Jilin University | Changchun | Jilin | 130061 | China |
Not provided
| ID | Term |
|---|---|
| D006505 | Hepatitis |
| D006526 | Hepatitis C |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood serum,Peripheral blood mononuclear cells (PBMC),Urine
| Baseline |
| Regular blood test | The distribution and absolute count of the different types of blood cells are assayed. | Baseline |
| Blood HCV RNA Copies | Blood HCV RNA copies were assayed with Roche - COBAS® AmpliPrep/COBAS® TaqMan® HCV Test. | Baseline |
| HCV genotype | HCV NS5A is cloned into T vector and sequenced for evolutionary analysis. | Baseline |
| Drug abuse history | Patients will be asked about their drug usage history. | Baseline |
| Alcohol ,smoking condition | Patients are asked whether they take alcohol or smoke cigarettes during the therapy period. | Baseline |
| D007239 | Infections |
| D006525 | Hepatitis, Viral, Human |
| D014777 | Virus Diseases |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |